Cart
sales@molnova.com
Fluorescamine
CAS No. 38183-12-9
Fluorescamine( Ro 20-7234 )
Catalog No. M24338 CAS No. 38183-12-9
Fluorescamine ( Ro 20-7234) is not fluorescent itself but reacts with primary amines to form highly fluorescent products. It is used to detect amines and peptides.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 30 | In Stock |
|
| 50MG | 45 | In Stock |
|
| 100MG | 57 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFluorescamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionFluorescamine ( Ro 20-7234) is not fluorescent itself but reacts with primary amines to form highly fluorescent products. It is used to detect amines and peptides.
-
DescriptionFluorescamine ( Ro 20-7234) is not fluorescent itself but reacts with primary amines to form highly fluorescent products. It is used to detect amines and peptides.
-
In Vitro——
-
In Vivo——
-
SynonymsRo 20-7234
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number38183-12-9
-
Formula Weight278.26
-
Molecular FormulaC17H10O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:30 mg/mL (107.81 mM)
-
SMILESO=C1C(c2ccccc2)=COC1(c1c2cccc1)OC2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
C-telopeptide
C-telopeptide, a cross-linked peptide of type I collagen, is released during bone resorption and has been correlated with bone mineral density (BMD).
-
Bragsin2
Bragsin2 is a hydration-resistant cell penetrant, selective and non-competitive inhibitor of Afr guanine nucleotide exchange factor BRAG2.
-
Inebilizumab
Inebilizumab is a humanized anti-CD19 monoclonal antibody with enhanced antibody-dependent cell-mediated cytotoxicity against B cells.
